to 1a–f) at a temperature of 25.0 0.2 ◦C. For the reactions
with half-lives of more than approx. one hour, apparent rate con-
stants were determined by initial-rate kinetics with the following
found: 438.0805; HPLC: Chiralpak AD, heptane/i-PrOH 90/10,
flow 1.0 mL min-1, Tr 37.1, 46.8 min.
3-(5-methoxy-1H-indol-3-yl)-1-(1-methyl-1H-imidazol-2-yl)-1-
octanone (3g). Purified by flash column chromatography (SiO2,
hexane–ethyl acetate 2 : 1, Rf 0.21), giving a brown oil. 1H NMR:
d 7.83 (br s, 1H), 7.20 (d, J = 9.0, 1H), 7.12 (d, 0.91, 1H), 7.05 (dd,
J = 2.4, 17.7, 2H), 6.96 (s, 1H), 6.81 (dd, J = 2.4, 8.7, 1H), 3.85 (s,
3H), 3.82 (s, 3H), 3.63–3.69 (m, 1H), 3.44–3.57 (m, 2H), 1.71–1.82
(m, 2H), 1.20–1.31 (m, 6H), 0.82 (t, 7.9, 3H), 13C NMR: d 192.3
(s), 153.5 (s), 143.2 (s), 131.4 (s), 128.6 (d), 127.3 (s), 126.7 (d),
121.8 (s), 119.1 (s), 111.7 (d), 111.6 (d), 101.0 (d), 55.8 (q), 45.6 (t),
36.0 (t), 36.0 (d), 32.2 (q), 31.9 (t), 27.1 (t), 22.5 (t), 14.0 (q); MS
(ESI) m/z 376 ([M+Na]+), 354 ([M+H]+), 149; HRMS calcd for
C21H28N3O2+ ([M+H]+): 354.2176, found: 354.2184; HPLC: Regis
(R,R)-Whelk-O 1, 0.04% diethylamine in heptane/i-PrOH 80/20,
flow 0.5 mL min-1, Tr 35.6, 42.3 min.
expression:13
in which d(Aenone)/dt
is the slope of the decrease of absorption in time, d the pathlength
of the cuvette (1 cm), De the difference in extinction coefficients of
the substrate and the product (determined separately) and [enone]0
is the initial substrate concentration. Apparent second-order rate
constants were then deduced from the slope of a plot of these
values of k1 versus the concentration of nucleophile. For faster
reactions (complete conversion within several hours, viz. Friedel–
Crafts alkylations of 2a,b by 1e–f), the decrease of absorption in
time (At) was curve-fitted using Grafit 3.0 (Erithacus Software
Ltd., 1992) to the exponential equation At = A• + A0·e-k1·t, giving
apparent rate constants k1 directly.
Synthesis of substrates and identification of products. Enone
substrates 1a–f22 were synthesized according to published pro-
cedures. Indoles 2a,b were commercially available from Sigma-
Aldrich and used without further purification. Analytical data
of adducts 3b,d–f, 5 and 6 were in accordance with literature.6,7
Addition products, for which initial-rate kinetics were used to
study rate constants, were synthesized independently as a race-
mate, starting from 0.25 mmol of enone, 0.25 mmol of copper(II)
nitrate and 5 eq. of the appropriate nucleophile in 5 mL of
distilled water overnight. The adducts were purified by flash-
column chromatography and their molar extinction coefficients
were determined in a concentration range close to that of the
catalytic reactions (typically 4–40 mM).
Conclusions
In the DNA-based catalytic enantioselective Michael addition and
Friedel–Crafts alkylation reaction, the role of the DNA is not
limited to that of a chiral scaffold. It was shown that in both these
conjugate addition reactions, the DNA affects the reaction rate,
with the largest rate accelerations observed in case of the Friedel–
Crafts alkylation. In the case of the Michael addition the effect is
dependent on the Michael donor: with dimethylmalonate a modest
increase of reaction rate was observed, whereas with nitromethane
a deceleration of the reaction was found in the presence of
DNA. The lower rates found for the Michael addition compared to
the Friedel–Crafts alkylation were attributed to charge repulsion
between the anionic nucleophile and the negatively charged DNA
backbone
From a comparison with the DNA-based catalytic enantiose-
lective Diels–Alder reaction, it was found that the role of DNA
is comparable in both reaction classes, suggesting that similar
factors play a role in the observed enantioselectivity and reaction
rate acceleration. It is suggested that the DNA predominantly has
an effect on the ground state of these reactions.
3-(5-methoxy-1H-indol-3-yl)-1-(1-methyl-1H-imidazol-2-yl)-3-
phenyl-1-propanone (3a). Purified by flash column chromato-
graphy (SiO2, hexane–ethyl acetate 1 : 2, Rf 0.25), giving a light
brown solid, mp 139 ◦C (dec.); 1H NMR: d 8.07 (br s, 1H), 7.38
(d, J 8.0, 2H), 7.20–7.26 (m, 2H), 7.11–7.20 (m, 3H), 7.09 (d, J =
2.4, 1H), 6.98 (s, 1H), 6.92 (d, J = 2.2, 1H), 6.78 (dd, J = 8.8, 2.4,
1H), 5.01 (t, J = 7.6, 1H), 4.01 (dd, J = 16.3, 7.4, 1H), 3.90 (s,
3H), 3.82 (dd, J = 16.4, 7.8, 1H), 3.75 (s, 3H);13C NMR: d 190.88
(s), 153.48 (s), 144.22 (s), 142.98 (s), 131.61 (s), 128.69 (d), 128.18
(d), 127.81 (d), 126.98 (s), 126.95 (d), 126.00 (d), 122.15 (d), 118.74
(s), 111.83 (d), 111.68 (d), 101.10 (d), 55.64 (q), 45.29 (t), 37.92
(d), 35.94 (q) MS (ESI) m/z 382 ([M+Na]+), 360 ([M+H]+), 236,
213; HRMS calcd for C22H22N3O2 ([M+H]+): 360.1707, found:
360.1700; HPLC: Chiralpak AD, heptane/i-PrOH 80/20, flow
1.0 mL min-1, Tr 19.1, 26.9 min.
Based on the observed generallity of the DNA-induced enan-
tioselectivity and rate acceleration, it is envisioned that the DNA-
based catalysis concept can be applied to other enantioselective
transition metal catalyzed reactions as well.
References
1 X. Y. Li and D. R. Liu, Angew. Chem., Int. Ed., 2004, 43, 4848.
2 T. Heinisch and T. R. Ward, Curr. Opin. Chem. Biol., 2010, 14, 184.
3 A. J. Boersma, R. P. Megens, B. L. Feringa and G. Roelfes, Chem. Soc.
Rev., 2010, 39, 2083.
4 G. Roelfes and B. L. Feringa, Angew. Chem., Int. Ed., 2005, 44, 3230.
5 G. Roelfes, A. J. Boersma and B. L. Feringa, Chem. Commun., 2006,
635.
6 D. Coquie`re, B. L. Feringa and G. Roelfes, Angew. Chem., Int. Ed.,
2007, 46, 9308.
7 A. J. Boersma, B. L. Feringa and G. Roelfes, Angew. Chem., Int. Ed.,
2009, 48, 3346.
8 E. W. Dijk, B. L. Feringa and G. Roelfes, Tetrahedron: Asymmetry,
2008, 19, 2374.
3-(4-bromophenyl)-3-(5-methoxy-1H-indol-3-yl)-1-(1-methyl-
1H-imidazol-2-yl)-1-propanone (3c). Purified by flash column
chromatography (SiO2, hexane–ethyl acetate 1 : 2, Rf 0.29), 1H
NMR: d 8.50 (br s, 1H), 7.55 (d, J = 7.9, 1H), 7.12–7.22 (m, 3H),
7.09 (t, J = 7.5, 1H), 7.04 (d, J = 2.4, 1H), 6.96–7.01 (m, 3H), 6.77
(dd, J = 2.4, 8.8, 1H), 5.47 (t, J = 7.7, 1H), 4.18 (dd, J = 8.1, 16.2,
1H), 3.90 (s, 3H), 3.76 (s, 3H), 3.56 (dd, J = 6.7, 16.2, 1H); 13C
NMR: d 190.40 (s), 153.72 (s), 143.16 (s), 143.06 (s), 132.66 (d),
131.56(s), 129.46 (d), 128.91 (d), 127.64 (d), 127.16 (s), 122.36 (d),
124.10 (s), 118.00 (s), 112.27 (d), 111.66 (d), 101.27 (d), 55.68 (q),
44.39 (t), 37.16 (d), 36.11 (q); MS (ESI) m/z 462 ([M+Na]+), 460
([M+Na]+), 440 ([M+H]+), 438 ([M+H]+), 422, 420, 316, 314, 293,
291, 122; HRMS calcd for C22H21BrN3O2 ([M+H]+): 438.0812,
9 P. Fournier, R. Fiammengo and A. Ja¨schke, Angew. Chem., Int. Ed.,
2009, 48, 4426.
10 Z. Tang, D. P. N. Gonc¸alves, M. Wieland, A. Marxs and J. S. Hartig,
ChemBioChem, 2008, 9, 1061.
3872 | Org. Biomol. Chem., 2010, 8, 3868–3873
This journal is
The Royal Society of Chemistry 2010
©